Ligelizumab improves sleep interference and disease burden in patients with chronic spontaneous urticaria
Abstract Background Chronic spontaneous urticaria (CSU) negatively impacts patients' sleep, thereby reducing health‐related quality of life (HRQoL). Half of patients with inadequately controlled CSU report sleep interference often or every night, which can lead to depression, anxiety, social, and wo...
Gardado en:
| Principais autores: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Wiley
2022-02-01
|
| Series: | Clinical and Translational Allergy |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1002/clt2.12121 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|